Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Phone+31 (0) 35 699 30 00


Bio Generation Fund, 11/2006


Naarden, NLD
Gooimeer 2-35
Naarden, 1411 DC, NLD


Managing Partner
Venture Partner


BioGeneration Ventures

BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands.

BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies.

The BioGeneration Ventures team is specialized in the evaluation and management of early stage companies. Their involvement goes beyond the financial investment. They work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to optimize the commercial potential of their portfolio company’s technologies. BioGeneration Ventures began operating in 2006 and the fund is backed by the Netherlands Genomics Initiative (NGI) and the Netherlands Organisation for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO Capital as lead private investors.

Recent Milestones


Company Date Round Size Participants
Lanthio Pharma 11/2012Series A€4.8M2
arGEN-X 2/2010Series A$4.5M7
Medisse 12/2009Venture Round1
arGEN-X 9/2009Series A$13.6M4
FlexGen 3/2009Venture Round2



  1. [edit]
  2. Lanthio Pharma Raises €4.8M in First Close of Series A funding ( [edit]
  3. arGEN-X, BV: Series A $4.5M ( [edit]
  4. Medisse Closes Funding From BioGeneration, Credit Agricole [edit]
  5. arGEN-X gins $13.6M in new funds for mAB work ( [edit]
  6. FlexGen closes new round of financing (PDF) ( [edit]
Edit This Page
Last Edited 2/9/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy